September 7th, 2011 by ChristopherChangMD in Research
No Comments »
So how would one go about figuring out the best medication for dizziness due to motion-sickness leading to nausea and even vomiting?
Well, step 1… Put a bunch of people in a machine and figure out the necessary motions that will cause dizziness.
Step 2… Do the same thing, but this time, put people on different medications and figure out what works the best.
Sound crazy?
Well it has been done by the friendly folks at NASA. Read more »
*This blog post was originally published at Fauquier ENT Blog*
September 5th, 2011 by AndrewSchorr in Opinion
No Comments »
Steve Jobs in 2010
It was a bombshell that shouldn’t have been unexpected. Steve Jobs resigning. Anyone who saw him knew he was sick and, just watching him on television, it was obvious to me he was getting sicker. When you get so thin, when your color is not good, when you are probably taking heavy duty drugs that have side effects, you certainly don’t feel good. And when you don’t feel good, it is tough to think clearly, and make decisions with certainty. That is not a good thing for the CEO of one of the most successful corporations. It is actually a tribute to his will that he carried on so long. Many of the rest of us would be on a beach, taking it easy and celebrating every day. Steve Jobs celebrated every day by running Apple.
But at some point, given life is a terminal condition anyway, you have to accept that “the beast,” whatever it is in your case, is winning. I know that for myself. I have had a long remission with leukemia. But I know it could come back and even newer drugs might not “win.” I am thankful for the success treatment has had for so long. And I am sure Steve Jobs is thankful his diagnosis several years ago didn’t lead to his demise right then. We thank him, too, for iPhones and iPads and several other wonderful gizmos he has in the works that will blossom in the future.
Knowing when to call it quits – not accepting death – but accepting disability or a need to spend time differently – is a hard part of being a patient, it stinks. But it is reality. Read more »
*This blog post was originally published at Andrew's Blog*
September 4th, 2011 by Berci in Opinion
1 Comment »
I’ve recently come across Medikidz, a fantastic initiative with a mission to help children understand medical information, especially diseases. I cannot imagine a better way to promote such important messages to children.
Millions of children worldwide are diagnosed every day with conditions that even their parents may find difficult to comprehend. Most children don’t understand their medical conditions, or associated investigations, procedures and treatments, and are often scared by what is going on around them.
That is where the Medikidz come into action!
The Medikidz are Read more »
*This blog post was originally published at ScienceRoll*
September 2nd, 2011 by RamonaBatesMD in Research
9 Comments »
I have written of keloid treatment (general, not site specific) previously. I have always tried to include pressure treatment as part of the plan when treating keloids of the ear lobe. This pressure treatment came in the form of pressure earrings — clip-on, disc-shaped.
The recent article (full reference below) in the Archives of Facial Plastic Surgery journal introduces a new pressure device which looks like it will work better than what has been available (photo credit)
and as can be seen in this photo, the upper ear can be treated with pressure which has not been possible with the clip earrings: Read more »
*This blog post was originally published at Suture for a Living*
August 21st, 2011 by ChristopherChangMD in Research
No Comments »
For real… at least in mice, but has potential for human application if the promise holds out!
MIT researchers have developed a radical new approach to eradicating viral infections no matter what the virus may be… common cold, HIV, Ebola, polio, dengue fever, etc.
The usual anti-viral antibiotics in use today target the viral replication process which unfortunately often fails with time as the virus adapts and develops resistance to the medication.
The new medication dubbed “DRACO” (Double-stranded RNA Activated Caspase Oligomerizers) approaches viral infections using a totally different approach. Read more »
*This blog post was originally published at Fauquier ENT Blog*
